Yubo International Biotech Limited announced earnings results for the third quarter ended November 30, 2020. For the third quarter, the company announced operating loss was USD 25,485 compared to USD 8,000 a year ago. Net loss was USD 25,485 compared to USD 34,000 a year ago. For the nine months, operating loss was USD 53,485 compared to USD 25,000 a year ago. Net income was USD 251,515 compared to net loss of USD 103,000 a year ago.